S
Shine+
Nootropic beverages for enhanced mental performance
About Shine+
Shine+ Drink is an Australian beverage company that created the country's first nootropic or 'smart' drink, designed to enhance mental performance. The company was co-founded in 2015 by Stephen Chapman and Dr. Sam Prince, who were seeking a healthy alternative to coffee and traditional energy drinks to maintain focus during long workdays. Chapman, who had prior startup experience, and Prince, a medical doctor and serial entrepreneur, identified a market gap for a beverage that could support cognitive function without the negative effects of sugar and artificial ingredients.
The company's core products are functional beverages formulated with natural nootropics and adaptogens, substances known to improve cognitive functions like focus, concentration, and memory. Key ingredients include Ginkgo Biloba, L-Theanine from green tea, Turmeric, Siberian Ginseng, and B vitamins. These ingredients work to provide a sustained, 'clean' focus without the crash associated with high-sugar, high-caffeine drinks. The business operates in the functional beverage market, a rapidly growing segment, by catering to health-conscious consumers seeking benefits beyond basic nutrition. Shine+ differentiates itself from traditional energy drinks by focusing on brain function rather than just a physical energy boost.
Initially launching with a 110ml shot, Shine+ quickly gained traction and expanded its product line to include various flavors in larger carbonated bottles and cans, such as the 'Charged' and zero-sugar ranges. The company's business model involves retail distribution through major outlets across Australia, including Coles, Woolworths, and 7-Eleven, alongside direct-to-consumer online sales. A core part of the company's ethos from its inception is a social responsibility component; through its Shine4Water campaign, the company donates one day of clean drinking water for every bottle sold.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Shenzhen, China
- Open positions
- None listed
- Dealroom signal
- 21.7/100
- Industry
- Chemicals
- Sector
- Chemicals, Hard Tech
- Business model
- Manufacturing
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Sep 2023 | $2.8M | $138M | L'Oréal china | ↗ |
| SERIES A✓Equity / VC | Jun 2022 | $28M | $110M | Bloomage Biotech · Oriental Fortune Capital · Hongtai Fund (Shenzhen) · Cowin Capital | ↗ |
Growth signals
Latest recorded traffic for Shine+ is 350 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Bloomage Biotech
Oriental Fortune Capital- H(Hongtai Fund (Shenzhen)
Cowin Capital
L'Oréal china
Other known investors1 additional known investor
- HAHongtai Aplus
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shine+ on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shine+’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







